Form 4: Integra LifeSciences Director Lo Renee Wonlai Reports Transaction
SEC Form 4 Filing
Director Lo Renee Wonlai reports acquisition and disposal of Integra LifeSciences Holdings Corp shares on May 9, 2025.
Summary
- On May 9, 2025, Lo Renee Wonlai, a director of Integra LifeSciences Holdings Corp, reported a transaction involving the company's common stock.
- The transaction included the acquisition of 19,592 shares and the disposal of 35,743 shares.
- Following the reported transactions, Wonlai beneficially owns 35,743 shares of Integra LifeSciences Holdings Corp.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of the stock transaction (acquisition and disposal). |
| 05/09/2025 | Date of Power of Attorney execution. |
| 05/13/2025 | Date of signature on the report. |
Keywords
Form 4, Integra LifeSciences, Director, Stock Transaction, Beneficial Ownership, IART, Lo Renee Wonlai
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.